Study finds early fluvoxamine treatment among COVID-19 patients reduces hospitalization

By | October 29, 2021
A team of researchers conducted a randomized, placebo-controlled, adaptive platform trial to evaluate the efficacy of fluvoxamine to prevent COVID-19 progression and hospitalization.